Masatoshi Eto
Kyushu University(JP)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Prostate Cancer Diagnosis and Treatment
Most-Cited Works
- → Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma(2021)1,691 cited
- → Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma(2011)265 cited
- → Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial(2018)254 cited
- → Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study(2023)151 cited
- → Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study(2024)137 cited
- → Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209